Jupiter Neurosciences (JUNS) Sof foyda bo'yicha sotuv rentabelligi

Jupiter Neurosciences Inc - JUNS emitenti grafik logotipi

Jupiter Neurosciences Inc (JUNS) kelgusidagi daromadlari resveratrolga asoslangan dori vositalarining bozorga chiqarilishiga bog'liq. Sof foyda marjasi biznesning operatsion samaradorligini aks ettiradi, bunda -17976.00 belgisi ushbu parametrni tavsiflaydi. Aktiv miya yallig'lanishiga qarshi kurashish uchun platforma ishlab chiqmoqda, yaxshilangan bio-mavjudlikka ega bo'lgan JPC-033 dorisi esa og'ir neyrodegenerativ patologiyalar terapiyasini maqsad qilgan.

Jupiter Neurosciences (JUNS) Sof foyda normasi: 04.12.2024 - 19.11.2026 davri uchun

Jupiter Neurosciences (JUNS) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
Kompaniyaning asosiy tahlili:jupiterneurosciences.com - JUNS
jupiterneurosciences.com ishlab chiqargan mahsulot

Sotuv marjasi daromadning har bir dollari ichidagi sof foyda ulushini o'lchaydi va daromadni kapitalga aylantirish samaradorligini belgilaydi. Biotech startapi Jupiter Neurosciences Inc. (JUNS) uchun ushbu hisob-kitob ishlab chiqarish zavodlarining yo'qligi va laboratoriya ishlanmalariga e'tibor qaratilganligi sababli murakkablashgan. Sof foyda marjasini tahlil qilish orqali investor operatsion xarajatlar bo'yicha real rentabellikni ko'rishi mumkin. Ushbu ko'rsatkichning tendentsiyasi biznes modelining bozor bosimiga chidamliligini tasdiqlaydi. Marjaning barqaror o'sishi resurslarni yuqori sifatli boshqarishdan dalolat beradi.

Jupiter Neurosciences Inc (JUNS) raqobatchilari

BIIB: Sotuvning sof marjinal rentabelligi|Sof marja Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Sotuvning sof marjinal rentabelligi|AXSM: Sof foyda normasi|Sof marja acadia-pharm.com (ACAD)|Sotuvning sof marjinal rentabelligi Xenon Pharmaceuticals (XENE)|Sof marja Viking Therapeutics VKTX|Sof foyda normasi SUPN|CPRX - Sof marja|Sof marja Denali Therapeutics|HRMY: Sotuvning sof marjinal rentabelligi|Biohaven - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi AMLX|Trevi Therapeutics, Inc. (TRVI) - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi PRAX (Praxis Medicines)|Anavex Corp - Sotuvning sof rentabelligi|Sof marja CeriBell CBLL|Kompaniya sotuv marjasi Prothena Biosciences (PRTA)|ALEC: Sof foyda bo'yicha sotuv rentabelligi|ANNX - Sotuvning sof marjinal rentabelligi|Omeros Corp. (OMER) - Sof marja|Sof marja Neurogene Inc. (NGNE)|Sof foyda bo'yicha sotuv rentabelligi ACIU|Sof marja VYGR|Sof marja Neumora (NMRA)|SCLX - Sof marja|Sotuvning sof marjinal rentabelligi TVGN (Tevogen Bio Holdings Inc.)|Sof foyda normasi ACOG|Cognition Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|IKT - Sotuvning sof marjinal rentabelligi|SAVA: Sotuvning sof marjinal rentabelligi|Assertio Holdings, Inc. - Sof foyda normasi|COYA (Coya) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi VTGN (Vistagen Therapeutics)|Sof marja Ovid Rx (OVID)|Acumen Pharmaceuticals - Sotuvning sof rentabelligi|Sof marja CervoMed, Inc. CRVO|Sotuvning sof marjinal rentabelligi Alterity Therapeutics ATHE|CLNN: Sof foyda bo'yicha sotuv rentabelligi|PEPG (pepgen.com) - Sotuvning sof rentabelligi|Relmada Therapeutics (RLMD) - Sof marja|ANVS (Annovis Bio, Inc.) - Sof marja|Sof marja gracetx.com|Sotuvning sof marjinal rentabelligi Firefly Neuroscience, Inc.|Sof marja ANEW Medical (KLTO)|NRSN - Sof marja|Sotuvning sof marjinal rentabelligi RVPH (Reviva Pharmaceuticals Holdings Inc.)|Kompaniyaning sof rentabelligi MTVA (metaviatx.com)|NeurAxis Inc. - Sotuvning sof marjinal rentabelligi|Kompaniya sotuv marjasi heliusmedical.com HSDT|PASG: Sotuvning sof marjinal rentabelligi|Neuphoria - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NERV|ATHA: Sof foyda normasi|Sof marja Addex Therapeutics Ltd (ADXN)|ALZN (Alzamend Neuro Inc.) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi CYCN (cyclerion.com)|Sof foyda bo'yicha marjinallik Protagenic|KTTA: Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi CRGT (cortigent.com)|ATXI: Sotuvning sof marjinal rentabelligi|BCLI (BrainStorm Cell Therapeutics) - Sof marja|CARA (Cara Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sof marja CHRO|Sof foyda bo'yicha sotuv rentabelligi ELYM (Eliem Therapeutics)|Sof marja ITCI (Intra-Cellular Therapies Inc.)|Sotuvning sof marjinal rentabelligi LBPH (Longboard Pharma)|Sotuvning sof marjinal rentabelligi Marinus Pharmaceuticals Inc MRNS|NKGen Biotech Corp - Sotuvning sof marjinal rentabelligi|Sof foyda normasi NRBO (NeuroBo Pharma)|SAGE (Sage Therapeutics, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi SNPX|Sof foyda bo'yicha sotuv rentabelligi TRVN|Sof marja VIGL|Sotuvning sof marjinal rentabelligi WENA|Kompaniya sotuv marjasi Cerevel